LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. TI=N acetyl l cystine NAC protects against H9N2 swine influenza virus induced acute lung injury
  2. TI=Liebe Leserin lieber Leser

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: N-acetyl-l-cystine (NAC) protects against H9N2 swine influenza virus-induced acute lung injury.

Zhang, Rui-Hua / Li, Chun-Hong / Wang, Cun-Lian / Xu, Ming-Ju / Xu, Tong / Wei, Dong / Liu, Bao-Jian / Wang, Guo-Hua / Tian, Shu-Fei

International immunopharmacology

2014  Volume 22, Issue 1, Page(s) 1–8

Abstract: ... human influenza A viruses. Here, the effects of NAC on H9N2 swine influenza virus-induced acute lung injury (ALI ... infective doses (TCID(50)) of A/swine/HeBei/012/2008/(H9N2) viruses with or without NAC treatments to induce ... swine influenza virus-infected mice. These results suggest that antioxidants like NAC represent a potential additional ...

Abstract The antioxidant N-acetyl-l-cysteine (NAC) had been shown to inhibit replication of seasonal human influenza A viruses. Here, the effects of NAC on H9N2 swine influenza virus-induced acute lung injury (ALI) were investigated in mice. BALB/c mice were inoculated intranasally with 10(7) 50% tissue culture infective doses (TCID(50)) of A/swine/HeBei/012/2008/(H9N2) viruses with or without NAC treatments to induce ALI model. The result showed that pulmonary inflammation, pulmonary edema, MPO activity, total cells, neutrophils, macrophages, TNF-α, IL-6, IL-1β and CXCL-10 in BALF were attenuated by NAC. Moreover, our data showed that NAC significantly inhibited the levels of TLR4 protein and TLR4 mRNA in the lungs. Pharmacological inhibitors of TLR4 (E5564) exerted similar effects like those determined for NAC in H9N2 swine influenza virus-infected mice. These results suggest that antioxidants like NAC represent a potential additional treatment option that could be considered in the case of an influenza A virus pandemic.
MeSH term(s) Acetylcysteine/administration & dosage ; Acute Lung Injury/etiology ; Acute Lung Injury/immunology ; Acute Lung Injury/prevention & control ; Animals ; Antioxidants/administration & dosage ; Cytokines/metabolism ; Disease Models, Animal ; Humans ; Inflammation Mediators/metabolism ; Influenza A Virus, H9N2 Subtype/drug effects ; Influenza A Virus, H9N2 Subtype/physiology ; Influenza, Human/drug therapy ; Influenza, Human/immunology ; Lipid A/administration & dosage ; Lipid A/analogs & derivatives ; Lipid A/pharmacology ; Lung/drug effects ; Lung/immunology ; Lung/virology ; Male ; Mice ; Mice, Inbred BALB C ; Orthomyxoviridae Infections/complications ; Orthomyxoviridae Infections/drug therapy ; Orthomyxoviridae Infections/immunology ; Peroxidase/metabolism ; Swine ; Toll-Like Receptor 4/antagonists & inhibitors ; Toll-Like Receptor 4/genetics ; Toll-Like Receptor 4/metabolism ; Virus Replication/drug effects
Chemical Substances Antioxidants ; Cytokines ; E5564 ; Inflammation Mediators ; Lipid A ; Toll-Like Receptor 4 ; Peroxidase (EC 1.11.1.7) ; Acetylcysteine (WYQ7N0BPYC)
Keywords covid19
Language English
Publishing date 2014-06-24
Publishing country Netherlands
Document type Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID 2043785-7
ISSN 1878-1705 ; 1567-5769
ISSN (online) 1878-1705
ISSN 1567-5769
DOI 10.1016/j.intimp.2014.06.013
Shelf mark
Zs.A 5408: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top